CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy

NCT03356912 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Castration-resistant Prostate Cancer

Interventions

DRUG: Cabazitaxel
DRUG: Prednisone

Sponsor

Consorzio Oncotech